C1458156||recurrence
C0007131||non-small-cell lung cancer
C0438113||cured
C1458156||recurrence
C0007131||non-small-cell lung cancer
C0007131||non-small-cell lung cancer
C1458156||recurrence
C1458156||recurrence
C0220825||evaluate
C1458156||recurrence
C0438113||cured
C0025102||medical records
C1458156||recurrence
C0728940||R0 resection
C0007131||pathological Stage IA-IIIA NSCLC
C1458156||recurrence
C0035363||analysed retrospectively
C0001418||adenocarcinoma
C0027643||locoregional (only) recurrence
C2919733||longer recurrence -free survival
C0006826||cancer
C1443775||epidermal growth factor receptor-tyrosine kinase inhibitor
C1443775||epidermal growth factor receptor-tyrosine kinase inhibitor
C0681493||curves
C0006826||cancer
C2911690||controlled
C0006826||cancer
C0006826||cancer
C2911690||controlled
C2986520||radical local therapy
C1458156||recurrence
C0007131||non-small-cell lung cancer
C1458156||recurrence
C0006826||cancer
C1457868||deteriorated
C0007131||non-small-cell lung cancer
C1458156||recurrence
C0220825||evaluated
C0006826||cancer
C2911690||controlled
C0438113||cured
C1257890||population
C0006826||cancer
C2911690||controlled